Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00788684
What this trial is testing

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Who this might be right for
CD20-Positive Lymphoid MalignanciesChronic Lymphoid LeukemiaHematological Malignancies+1 more
AbbVie 29
Testing effectiveness (Phase 2)Ended earlyNCT01596127
What this trial is testing

Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System

Who this might be right for
LeukemiaLymphoid MalignanciesMetastatic Malignant Neoplasm to the Leptomeninges
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Ended earlyNCT02951156
What this trial is testing

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 29
Testing effectiveness (Phase 2)Study completedNCT00285428
What this trial is testing

Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Gilead Sciences 82
Early research (Phase 1)Active Not RecruitingNCT05737628
What this trial is testing

First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228

Who this might be right for
Lymphoma
Byondis B.V. 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04548999
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 769
Testing effectiveness (Phase 2)Looking for participantsNCT07510607
What this trial is testing

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRRMSRelapsing Remitting MS
Ari Green 40
Large-scale testing (Phase 3)Study completedNCT01724021
What this trial is testing

Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

Who this might be right for
Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma
Hoffmann-La Roche 743
Post-approval studies (Phase 4)UnknownNCT05596526
What this trial is testing

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

Who this might be right for
ShinglesZoster
Prof Patrice Lalive 100
Testing effectiveness (Phase 2)Study completedNCT00774462
What this trial is testing

Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis

Who this might be right for
MyositisMyasthenia Gravis
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT06894940
What this trial is testing

Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

Who this might be right for
Multiple Sclerosis
University of Pavia 82
Large-scale testing (Phase 3)Study completedNCT01609010
What this trial is testing

MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 313
Testing effectiveness (Phase 2)Looking for participantsNCT04920968
What this trial is testing

Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"

Who this might be right for
CD20-positive Acute Lymphoblastic Leukemia
Maria Sklodowska-Curie National Research Institute of Oncology 124
Testing effectiveness (Phase 2)Study completedNCT00690560
What this trial is testing

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Centre Antoine Lacassagne 30
Testing effectiveness (Phase 2)Study completedNCT01087424
What this trial is testing

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Lymphoma Study Association 150
Early research (Phase 1)Study completedNCT01680991
What this trial is testing

Obinutuzumab in Chinese Participants With CD20+ Malignant Disease

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
Hoffmann-La Roche 48
Large-scale testing (Phase 3)Ended earlyNCT00006708
What this trial is testing

S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 7
Post-approval studies (Phase 4)Study completedNCT00926757
What this trial is testing

Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B

Who this might be right for
Non Hodgkin's LymphomaHepatitis B
Taipei Veterans General Hospital, Taiwan 80
Large-scale testing (Phase 3)UnknownNCT01277172
What this trial is testing

TREatment of degeNerative and Neoplastic Diseases With Rituximab

Who this might be right for
Diffuse Large B Cell Lymphoma
Probiomed S.A. de C.V. 54
Early research (Phase 1)Study completedNCT04696432
What this trial is testing

C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital 7
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation